世界の組換えヒトエンドスタチン市場レポート2020年

QYResearchが発行した調査報告書(QYR21FB12114)
◆英語タイトル:Global Recombinant Human Endostatin Sales Market Report 2020
◆商品コード:QYR21FB12114
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:132
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の組換えヒトエンドスタチン市場について種類別(純度:95%、その他)、用途別(医療、科学研究、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・組換えヒトエンドスタチン市場の概要
・世界の主要地域別組換えヒトエンドスタチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の組換えヒトエンドスタチン市場規模2015-2026:種類別(純度:95%、その他)
・世界の組換えヒトエンドスタチン市場規模2015-2026:用途別(医療、科学研究、その他)
・組換えヒトエンドスタチンのアメリカ市場規模2015-2020
・組換えヒトエンドスタチンのヨーロッパ市場規模2015-2020
・組換えヒトエンドスタチンの中国市場規模2015-2020
・組換えヒトエンドスタチンの日本市場規模2015-2020
・組換えヒトエンドスタチンの東南アジア市場規模2015-2020
・組換えヒトエンドスタチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・組換えヒトエンドスタチンの製造コスト分析
・販売チャネル、流通業者、顧客
・組換えヒトエンドスタチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294.

Market Analysis and Insights: Global Recombinant Human Endostatin Market
The global Recombinant Human Endostatin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Recombinant Human Endostatin Scope and Market Size
The global Recombinant Human Endostatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Endostatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Recombinant Human Endostatin market is segmented into
Purity:95%
Others

Segment by Application, the Recombinant Human Endostatin market is segmented into
Medical Care
Scientific Research
Others

The Recombinant Human Endostatin market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Human Endostatin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Recombinant Human Endostatin Market Share Analysis
Recombinant Human Endostatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Human Endostatin business, the date to enter into the Recombinant Human Endostatin market, Recombinant Human Endostatin product introduction, recent developments, etc.

The major vendors covered:
Thermo Fisher Scientific
PeproTech

【レポートの目次】

1 Recombinant Human Endostatin Market Overview
1.1 Recombinant Human Endostatin Product Scope
1.2 Recombinant Human Endostatin Segment by Type
1.2.1 Global Recombinant Human Endostatin Sales by Type (2020-2026)
1.2.2 Purity:95%
1.2.3 Others
1.3 Recombinant Human Endostatin Segment by Application
1.3.1 Global Recombinant Human Endostatin Sales Comparison by Application (2020-2026)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Recombinant Human Endostatin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Human Endostatin Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Human Endostatin Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Human Endostatin Price Trends (2015-2026)

2 Recombinant Human Endostatin Estimate and Forecast by Region
2.1 Global Recombinant Human Endostatin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Human Endostatin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Human Endostatin Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Human Endostatin Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Human Endostatin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Human Endostatin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Human Endostatin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.3 China Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Human Endostatin Estimates and Projections (2015-2026)
2.4.6 India Recombinant Human Endostatin Estimates and Projections (2015-2026)
3 Global Recombinant Human Endostatin Competition Landscape by Players
3.1 Global Top Recombinant Human Endostatin Players by Sales (2015-2020)
3.2 Global Top Recombinant Human Endostatin Players by Revenue (2015-2020)
3.3 Global Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Endostatin as of 2019)
3.4 Global Recombinant Human Endostatin Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Human Endostatin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Human Endostatin Players (Opinion Leaders)
4 Global Recombinant Human Endostatin Market Size by Type
4.1 Global Recombinant Human Endostatin Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Human Endostatin Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Human Endostatin Price by Type (2015-2020)
4.2 Global Recombinant Human Endostatin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Human Endostatin Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Human Endostatin Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Human Endostatin Price Forecast by Type (2021-2026)
5 Global Recombinant Human Endostatin Market Size by Application
5.1 Global Recombinant Human Endostatin Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Human Endostatin Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Human Endostatin Price by Application (2015-2020)
5.2 Global Recombinant Human Endostatin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Human Endostatin Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Human Endostatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Human Endostatin Price Forecast by Application (2021-2026)

6 United States Recombinant Human Endostatin Market Facts & Figures
6.1 United States Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
6.2 United States Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
6.3 United States Recombinant Human Endostatin Sales Market Share by Application (2015-2020)

7 Europe Recombinant Human Endostatin Market Facts & Figures
7.1 Europe Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
7.2 Europe Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
7.3 Europe Recombinant Human Endostatin Sales Market Share by Application (2015-2020)

8 China Recombinant Human Endostatin Market Facts & Figures
8.1 China Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
8.2 China Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
8.3 China Recombinant Human Endostatin Sales Market Share by Application (2015-2020)

9 Japan Recombinant Human Endostatin Market Facts & Figures
9.1 Japan Recombinant Human Endostatin Sales Market Share by Company (3015-3030)
9.2 Japan Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
9.3 Japan Recombinant Human Endostatin Sales Market Share by Application (2015-2020)

10 Southeast Asia Recombinant Human Endostatin Market Facts & Figures
10.1 Southeast Asia Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Recombinant Human Endostatin Sales Market Share by Application (2015-2020)

11 India Recombinant Human Endostatin Market Facts & Figures
11.1 India Recombinant Human Endostatin Sales Market Share by Company (2015-2020)
11.2 India Recombinant Human Endostatin Sales Market Share by Type (2015-2020)
11.3 India Recombinant Human Endostatin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Recombinant Human Endostatin Business
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Products Offered
12.1.5 Thermo Fisher Scientific Recent Development
12.2 PeproTech
12.2.1 PeproTech Corporation Information
12.2.2 PeproTech Business Overview
12.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 PeproTech Recombinant Human Endostatin Products Offered
12.2.5 PeproTech Recent Development

13 Recombinant Human Endostatin Manufacturing Cost Analysis
13.1 Recombinant Human Endostatin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Human Endostatin
13.4 Recombinant Human Endostatin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Human Endostatin Distributors List
14.3 Recombinant Human Endostatin Customers

15 Market Dynamics
15.1 Recombinant Human Endostatin Market Trends
15.2 Recombinant Human Endostatin Opportunities and Drivers
15.3 Recombinant Human Endostatin Market Challenges
15.4 Recombinant Human Endostatin Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【掲載企業】

Thermo Fisher Scientific、PeproTech

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の組換えヒトエンドスタチン市場レポート2020年(Global Recombinant Human Endostatin Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。